全文获取类型
收费全文 | 1068124篇 |
免费 | 73088篇 |
国内免费 | 1363篇 |
学科分类
医药卫生 | 1142575篇 |
出版年
2019年 | 7764篇 |
2018年 | 11303篇 |
2017年 | 8913篇 |
2016年 | 10108篇 |
2015年 | 11279篇 |
2014年 | 15282篇 |
2013年 | 22222篇 |
2012年 | 30570篇 |
2011年 | 32315篇 |
2010年 | 18964篇 |
2009年 | 17824篇 |
2008年 | 29974篇 |
2007年 | 32099篇 |
2006年 | 32748篇 |
2005年 | 31093篇 |
2004年 | 29761篇 |
2003年 | 28589篇 |
2002年 | 27542篇 |
2001年 | 59971篇 |
2000年 | 61379篇 |
1999年 | 50722篇 |
1998年 | 11850篇 |
1997年 | 10393篇 |
1996年 | 10338篇 |
1995年 | 10281篇 |
1994年 | 9319篇 |
1993年 | 8819篇 |
1992年 | 37772篇 |
1991年 | 36279篇 |
1990年 | 35734篇 |
1989年 | 34281篇 |
1988年 | 30853篇 |
1987年 | 29979篇 |
1986年 | 28208篇 |
1985年 | 26444篇 |
1984年 | 19176篇 |
1983年 | 16090篇 |
1982年 | 8793篇 |
1979年 | 16995篇 |
1978年 | 11377篇 |
1977年 | 10193篇 |
1976年 | 8822篇 |
1975年 | 10047篇 |
1974年 | 11636篇 |
1973年 | 11259篇 |
1972年 | 10744篇 |
1971年 | 10085篇 |
1970年 | 9243篇 |
1969年 | 8925篇 |
1968年 | 7909篇 |
排序方式: 共有10000条查询结果,搜索用时 140 毫秒
991.
Heather G. Allore PhD Keith S. Goldfeld DrPH Roee Gutman PhD Fan Li PhD Joan K. Monin PhD Monica Taljaard PhD Thomas G. Travison PhD 《Journal of the American Geriatrics Society》2020,68(Z2):S68-S73
There is overwhelming need for nonpharmacological interventions to improve the health and well-being of people living with dementia (PLWD). The National Institute on Aging Imbedded Pragmatic Alzheimer's Disease (AD) and AD-Related Dementias Clinical Trials (IMPACT) Collaboratory supports clinical trials of such interventions embedded in healthcare systems. The embedded pragmatic clinical trial (ePCT) is ideally suited to testing the effectiveness of complex interventions in vulnerable populations at the point of care. These trials, however, are complex to conduct and interpret, and face challenges in efficiency (i.e., statistical power) and reproducibility. In addition, trials conducted among PLWD present specific statistical challenges, including difficulty in outcomes ascertainment from PLWD, necessitating reliance on reports by caregivers, and heterogeneity in measurements across different settings or populations. These and other challenges undercut the reliability of measurement, the feasibility of capturing outcomes using pragmatic designs, and the ability to validly estimate interventions' effectiveness in real-world settings. To address these challenges, the IMPACT Collaboratory has convened a Design and Statistics Core, the goals of which are: to support the design and conduct of ePCTs directed toward PLWD and their caregivers; to develop guidance for conducting embedded trials in this population; and to educate quantitative and clinical scientists in the design, conduct, and analysis of these trials. In this article, we discuss some of the contemporary methodological challenges in this area and develop a set of research priorities the Design and Statistics Core will undertake to meet these goals. J Am Geriatr Soc 68:S68–S73, 2020 . 相似文献
992.
993.
994.
995.
996.
997.
998.
999.
Cardiovascular complications remain the main cause of mortality and morbidity in diabetes. This is related to advanced vascular pathology in this population, together with an enhanced thrombotic environment. The increased risk in thrombosis is secondary to platelet hyper-reactivity and increased levels and/or altered activity of coagulation factors. The current review is focused on the role of antiplatelet agents in modulating the thrombotic milieu in diabetes and improving vascular outcome in this high-risk population. We review the latest evidence for the use of aspirin in primary vascular prevention together with long-term treatment with this agent for secondary prevention. We also discuss the effects of the various P2Y12 inhibitors, including clopidogrel, prasugrel and ticagrelor, on both short- and long-term secondary vascular prevention. Moreover, we briefly review antiplatelet therapies in special groups of people including those intolerant to aspirin, individuals with peripheral vascular disease and those with cerebrovascular pathology. The overall aim of this review is to provide the healthcare professional with a pragmatic guide for the management of thrombotic risk using established antiplatelet therapies to improve vascular outcome in persons with diabetes. 相似文献
1000.